A detailed history of Buckingham Strategic Partners transactions in Medtronic PLC stock. As of the latest transaction made, Buckingham Strategic Partners holds 8,589 shares of MDT stock, worth $727,831. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,589
Previous 9,521 9.79%
Holding current value
$727,831
Previous $749,000 3.2%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$76.84 - $91.03 $71,614 - $84,839
-932 Reduced 9.79%
8,589 $773,000
Q2 2024

Aug 13, 2024

SELL
$78.71 - $87.02 $348,685 - $385,498
-4,430 Reduced 31.75%
9,521 $749,000
Q1 2024

May 15, 2024

BUY
$82.84 - $88.09 $717,891 - $763,387
8,666 Added 163.97%
13,951 $1.22 Million
Q4 2023

Feb 14, 2024

SELL
$69.43 - $83.43 $64,083 - $77,005
-923 Reduced 14.87%
5,285 $435,000
Q3 2023

Nov 14, 2023

BUY
$78.22 - $90.4 $101,998 - $117,881
1,304 Added 26.59%
6,208 $486,000
Q2 2023

Aug 14, 2023

BUY
$79.47 - $91.38 $38,542 - $44,319
485 Added 10.98%
4,904 $432,000
Q1 2023

May 15, 2023

BUY
$76.72 - $87.58 $39,740 - $45,366
518 Added 13.28%
4,419 $356,000
Q4 2022

Feb 14, 2023

SELL
$76.18 - $87.74 $15,007 - $17,284
-197 Reduced 4.81%
3,901 $303,000
Q3 2022

Nov 14, 2022

BUY
$80.75 - $95.31 $330,913 - $390,580
4,098 New
4,098 $331,000
Q2 2022

Aug 12, 2022

SELL
$87.4 - $113.09 $242,185 - $313,372
-2,771 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$100.58 - $112.38 $53,508 - $59,786
532 Added 23.76%
2,771 $307,000
Q4 2021

Feb 10, 2022

BUY
$99.53 - $127.75 $222,847 - $286,032
2,239 New
2,239 $231,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $113B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Buckingham Strategic Partners Portfolio

Follow Buckingham Strategic Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Strategic Partners, based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Strategic Partners with notifications on news.